Literature DB >> 19153775

Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome.

Anna Iharada1, Kazunari Kaneko, Shoji Tsuji, Masafumi Hasui, Seiji Kanda, Toshimasa Nishiyama.   

Abstract

The pathogenesis of idiopathic nephrotic syndrome (INS) remains unclear. To study the role of nitric oxide (NO) in INS, we measured intracellular NO produced by T- and B-cells using a novel fluorescent indicator. Twelve children with INS (mean age 7.3 years; group A-1: in relapse, group A-2: in remission) were enrolled in the study together with 16 children with other renal diseases (9.5 years; group B) and 42 healthy control children (7.7 years; group C). The amount of NO produced by CD3+ cells (T-cells) and CD19+ cells (B-cells) and of plasma NO(x) was measured by flow cytometry and colorimetry, respectively. The average amount of NO produced by CD3+ and CD19+ cells in group A-1 subjects was significantly higher than that produced by these cells in group A-2 and B patients and the healthy controls (group C), respectively (P < 0.01), and it decreased after the patients achieved remission (P < 0.01). Plasma NO(x) levels in group A-1 patients was also highest among the different groups (P < 0.01). There were no significant differences in intracellular NO and plasma NO(x) among group A-2, B, and C subjects (P > 0.05). A significant correlation between plasma NO(x) and urinary protein excretion was found only in group A patients and not in group B patients. We conclude that an aberrant immune system may exist not only in T-cells but also in B-cells, and NO may play some role in INS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153775     DOI: 10.1007/s00467-008-1092-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  24 in total

1.  Adrenomedullin and nitrite levels in children with minimal change nephrotic syndrome.

Authors:  A Balat; M Cekmen; M Yürekli; H Gülcan; O Kutlu; Y Türköz; S Yologlu
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

2.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

3.  Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.

Authors:  Tomonosuke Someya; Kazunari Kaneko; Toshiyuki Yamada; Yuichiro Yamashiro
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

4.  Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome.

Authors:  M J Kemper; T Meyer-Jark; M Lilova; D E Müller-Wiefel
Journal:  Clin Nephrol       Date:  2003-10       Impact factor: 0.975

5.  A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells.

Authors:  Anne-Laure Sellier-Leclerc; Arnaud Duval; Stéphanie Riveron; Marie-Alice Macher; Georges Deschenes; Chantal Loirat; Marie-Christine Verpont; Michel Peuchmaur; Pierre Ronco; Renato C Monteiro; Elie Haddad
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

Review 6.  Nephrotic syndrome in childhood.

Authors:  Allison A Eddy; Jordan M Symons
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

Review 7.  Nitric oxide in the kidney: synthesis, localization, and function.

Authors:  S Bachmann; P Mundel
Journal:  Am J Kidney Dis       Date:  1994-07       Impact factor: 8.860

Review 8.  A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos E Araya; Clive H Wasserfall; Todd M Brusko; Wei Mu; Mark S Segal; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

9.  Increased urinary nitrite excretion in children with minimal change nephrotic syndrome.

Authors:  H Trachtman; B Gauthier; R Frank; S Futterweit; A Goldstein; J Tomczak
Journal:  J Pediatr       Date:  1996-02       Impact factor: 4.406

10.  Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.

Authors:  H Kojima; N Nakatsubo; K Kikuchi; S Kawahara; Y Kirino; H Nagoshi; Y Hirata; T Nagano
Journal:  Anal Chem       Date:  1998-07-01       Impact factor: 6.986

View more
  7 in total

Review 1.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

2.  Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.

Authors:  Juhi Kumar; Ibrahim F Shatat; Amy L Skversky; Robert P Woroniecki; Marcela Del Rio; Eduardo M Perelstein; Valerie L Johnson; Shefali Mahesh
Journal:  Pediatr Nephrol       Date:  2012-10-04       Impact factor: 3.714

3.  Minimal change nephrotic syndrome and prohibitin-2 gene polymorphism.

Authors:  Keisuke Sugimoto; Tomoki Miyazawa; Kohei Miyazaki; Hidehiko Yanagida; Takuji Enya; Hitomi Nishi; Norihisa Wada; Mitsuru Okada; Tsukasa Takemura
Journal:  Clin Exp Nephrol       Date:  2016-11-04       Impact factor: 2.801

Review 4.  Nephrotic syndrome and rituximab: facts and perspectives.

Authors:  Dieter Haffner; Dagmar-Christiane Fischer
Journal:  Pediatr Nephrol       Date:  2009-06-04       Impact factor: 3.714

5.  Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.

Authors:  Stéphanie Tellier; Karine Brochard; Arnaud Garnier; Flavio Bandin; Brigitte Llanas; Vincent Guigonis; Mathilde Cailliez; Christine Pietrement; Olivier Dunand; Sylvie Nathanson; Aurélia Bertholet-Thomas; Lydia Ichay; Stéphane Decramer
Journal:  Pediatr Nephrol       Date:  2013-01-23       Impact factor: 3.714

6.  The effect of systemic corticosteroids on the innate and adaptive immune system in children with steroid responsive nephrotic syndrome.

Authors:  Hatice Ezgi Baris; Safa Baris; Elif Karakoc-Aydiner; Ibrahim Gokce; Nurdan Yildiz; Dilek Cicekkoku; Ismail Ogulur; Ahmet Ozen; Harika Alpay; Isil Barlan
Journal:  Eur J Pediatr       Date:  2016-01-30       Impact factor: 3.183

7.  The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review.

Authors:  Carlos E Araya; Vikas R Dharnidharka
Journal:  J Transplant       Date:  2011-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.